The Dementia Discovery Fund is the world’s largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease.
The DDF has raised a total of £250 million to develop novel disease-modifying therapeutics for all forms of dementia.
They have a mandate to validate novel hypotheses and
expand the breadth of targets and mechanisms in development for dementia over the 15 year life of the fund.
This enables the DDF to invest in truly novel, early-stage projects starting from target identification, and explore novel biological insights for translation into disease-modifying drugs.
Industries: Biotechnology
Life Science
Health Care
Therapeutics
Medical
Pharmaceutical
Clinical Trials
Health Diagnostics
Medical Device
mHealth
Neuroscience
Location: London, England, United Kingdom
